Parvizi, J. Et Al. 2023. Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?. JOURNAL OF ARTHROPLASTY , vol.38, no.1 , 1-2.

Parvizi, J., DeMik, D. E., Hozack, W. J., Dunbar, M. J., Mont, M. A., & Lachiewicz, P. F., (2023). Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?. JOURNAL OF ARTHROPLASTY , vol.38, no.1, 1-2.

Parvizi, JAVAD Et Al. "Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?," JOURNAL OF ARTHROPLASTY , vol.38, no.1, 1-2, 2023

Parvizi, JAVAD Et Al. "Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?." JOURNAL OF ARTHROPLASTY , vol.38, no.1, pp.1-2, 2023

Parvizi, J. Et Al. (2023) . "Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?." JOURNAL OF ARTHROPLASTY , vol.38, no.1, pp.1-2.

@article{article, author={JAVAD PARVİZİ Et Al. }, title={Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?}, journal={JOURNAL OF ARTHROPLASTY}, year=2023, pages={1-2} }